ONTOLOGY REPORT - ANNOTATIONS
| Term: | peptide cross-linking |
|
| Accession: | GO:0018149
|
browse the term
|
| Definition: | The formation of a covalent cross-link between or within protein chains. |
|
|
peptide cross-linking
|
| G |
Anxa1 |
annexin A1 |
|
|
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:1624291 |
RGD |
| G |
Anxa1 |
annexin A1 |
|
|
IEA |
1 |
223,478,436 |
223,494,455 |
RGD:1600115 |
ENSEMBL |
| G |
Col3a1 |
collagen, type III, alpha 1 |
|
|
IEA |
9 |
44,281,582 |
44,317,831 |
RGD:1600115 |
ENSEMBL |
| G |
Csta |
cystatin A (stefin A) |
|
|
ISO |
11 |
66,456,248 |
66,467,253 |
RGD:1624291 |
RGD |
| G |
Dsp |
desmoplakin |
|
|
ISO |
17 |
32,848,313 |
32,896,044 |
RGD:1624291 |
RGD |
| G |
Dsp |
desmoplakin |
|
|
IEA |
17 |
32,848,313 |
32,896,044 |
RGD:1600115 |
ENSEMBL |
| G |
Epb42 |
erythrocyte membrane protein band 4.2 |
|
|
IEA |
3 |
107,806,273 |
107,824,496 |
RGD:1600115 |
InterPro |
| G |
Evpl |
envoplakin |
|
|
ISO |
10 |
106,336,953 |
106,353,217 |
RGD:1624291 |
RGD |
| G |
F13a1 |
coagulation factor XIII, A1 polypeptide |
|
|
ISO |
17 |
34,093,525 |
34,270,498 |
RGD:1624291 |
RGD |
| G |
F13a1 |
coagulation factor XIII, A1 polypeptide |
|
|
IEA |
17 |
34,093,525 |
34,270,498 |
RGD:1600115 |
ENSEMBL |
| G |
F13a1 |
coagulation factor XIII, A1 polypeptide |
|
|
IEA |
17 |
34,093,525 |
34,270,498 |
RGD:1600115 |
InterPro |
| G |
Fn1 |
fibronectin 1 |
|
|
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:1624291 |
RGD |
| G |
Ivl |
involucrin |
|
|
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:1624291 |
RGD |
| G |
Ivl |
involucrin |
|
|
IEA |
2 |
185,556,271 |
185,558,310 |
RGD:1600115 |
ENSEMBL |
| G |
Lor |
loricrin |
|
|
ISO |
2 |
184,953,538 |
184,955,283 |
RGD:1624291 |
RGD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
|
ISO |
2 |
185,463,951 |
185,465,849 |
RGD:1624291 |
RGD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
|
IEA |
2 |
185,463,951 |
185,465,849 |
RGD:1600115 |
InterPro |
| G |
Sprr1b |
small proline-rich protein 1B |
|
|
ISO |
2 |
185,418,131 |
185,418,568 |
RGD:1624291 |
RGD |
| G |
Sprr3 |
small proline-rich protein 3 |
|
|
IEA |
2 |
185,436,598 |
185,437,356 |
RGD:1600115 |
InterPro |
| G |
Tgm1 |
transglutaminase 1 |
|
|
NAS |
15 |
33,846,367 |
33,859,615 |
RGD:61767 |
RGD |
| G |
Tgm3 |
transglutaminase 3, E polypeptide |
|
|
ISO |
3 |
117,622,727 |
117,659,103 |
RGD:1624291 |
RGD |
| G |
Tgm3 |
transglutaminase 3, E polypeptide |
|
|
IEA |
3 |
117,622,727 |
117,659,103 |
RGD:1600115 |
ENSEMBL |
| G |
Tgm4 |
transglutaminase 4 (prostate) |
|
|
IEA |
8 |
127,782,460 |
127,819,491 |
RGD:1600115 |
InterPro |
| G |
Tgm5 |
transglutaminase 5 |
|
|
IEA |
3 |
107,834,647 |
107,864,542 |
RGD:1600115 |
InterPro |
| G |
Tgm6 |
transglutaminase 6 |
|
|
IEA |
3 |
117,722,990 |
117,753,457 |
RGD:1600115 |
InterPro |
| G |
Tgm7 |
transglutaminase 7 |
|
|
IEA |
3 |
107,880,960 |
107,905,261 |
RGD:1600115 |
InterPro |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine
|
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
|
IDA |
3 |
148,832,866 |
148,862,385 |
RGD:1579955 |
RGD |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan
|
| G |
Bgn |
biglycan |
|
|
ISO |
X |
159,380,557 |
159,393,409 |
RGD:1624291 |
RGD |
| G |
Bgn |
biglycan |
|
|
IEA |
X |
159,380,557 |
159,393,409 |
RGD:1600115 |
ENSEMBL |
| G |
Dcn |
decorin |
|
|
ISO |
7 |
35,004,234 |
35,045,191 |
RGD:1624291 |
RGD |
| G |
Dcn |
decorin |
|
|
IEA |
7 |
35,004,234 |
35,045,191 |
RGD:1600115 |
ENSEMBL |
| G |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
|
|
ISO |
2 |
56,493,064 |
56,666,659 |
RGD:1624291 |
RGD |
| G |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
|
|
IEA |
2 |
56,493,064 |
56,666,659 |
RGD:1600115 |
ENSEMBL |
| G |
Prss34 |
protease, serine, 34 |
|
|
ISO |
10 |
14,546,640 |
14,548,397 |
RGD:1624291 |
RGD |
| G |
Prss34 |
protease, serine, 34 |
|
|
IEA |
10 |
14,546,640 |
14,548,397 |
RGD:1600115 |
ENSEMBL |
| G |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
|
|
ISO |
20 |
27,397,527 |
27,425,914 |
RGD:1624291 |
RGD |
| G |
Spock3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
|
|
ISO |
16 |
29,337,211 |
29,751,950 |
RGD:1624291 |
RGD |
Term paths to the root
| Path 1 |
biological_process |
136531 |
 |
metabolic process |
36512 |
 |
cellular metabolic process |
30527 |
 |
cellular macromolecule metabolic process |
21896 |
 |
cellular protein metabolic process |
8800 |
 |
cellular protein modification process |
6858 |
 |
peptide cross-linking |
38 |
 |
isopeptide cross-linking + |
1 |
 |
peptide cross-linking via (2S,3S,4Xi,6R)-3-methyl-lanthionine sulfoxide |
0 |
 |
peptide cross-linking via (2S,3S,6R)-3-methyl-lanthionine |
0 |
 |
peptide cross-linking via 2'-(S-L-cysteinyl)-L-histidine |
0 |
 |
peptide cross-linking via 2-(S-L-cysteinyl)-D-allo-threonine |
0 |
 |
peptide cross-linking via 2-(S-L-cysteinyl)-D-phenylalanine |
0 |
 |
peptide cross-linking via 2-(S-L-cysteinyl)-L-phenylalanine |
0 |
 |
peptide cross-linking via 2-imino-glutamic acid 5-imidazolinone glycine |
0 |
 |
peptide cross-linking via 2-imino-glutaminyl-5-imidazolinone glycine |
0 |
 |
peptide cross-linking via 2-imino-methionine 5-imidazolinone glycine |
0 |
 |
peptide cross-linking via 3'-(3'-L-tyrosinyl)-L-tyrosine |
0 |
 |
peptide cross-linking via 3'-(O4'-L-tyrosinyl)-L-tyrosine |
0 |
 |
peptide cross-linking via 3'-(S-L-cysteinyl)-L-tyrosine |
0 |
 |
peptide cross-linking via 3-(2-methylthio)ethyl-6-(4-hydroxybenzylidene)-5-iminopiperazin-2-one |
0 |
 |
peptide cross-linking via 3-(S-L-cysteinyl)-L-aspartic acid |
0 |
 |
peptide cross-linking via 4'-(L-tryptophan)-L-tryptophyl quinone + |
0 |
 |
peptide cross-linking via 4'-(S-L-cysteinyl)-L-tryptophyl quinone |
0 |
 |
peptide cross-linking via 4-(S-L-cysteinyl)-L-glutamic acid |
0 |
 |
peptide cross-linking via 4-amino-3-isothiazolidinone + |
0 |
 |
peptide cross-linking via 5'-(N6-L-lysine)-L-topaquinone |
0 |
 |
peptide cross-linking via 5-imidazolinone glycine + |
0 |
 |
peptide cross-linking via L-cysteinyl-L-selenocysteine |
0 |
 |
peptide cross-linking via L-cystine |
0 |
 |
peptide cross-linking via L-histidyl-L-tyrosine + |
0 |
 |
peptide cross-linking via L-lysinoalanine |
0 |
 |
peptide cross-linking via N6-(L-isoaspartyl)-L-lysine + |
0 |
 |
peptide cross-linking via S-(2-aminovinyl)-3-methyl-D-cysteine |
0 |
 |
peptide cross-linking via S-(2-aminovinyl)-D-cysteine |
0 |
 |
peptide cross-linking via S-(L-isoglutamyl)-L-cysteine |
0 |
 |
peptide cross-linking via S-[5'-(L-tryptoph-6'-yl)-L-tyrosin-3'-yl]-L-methionin-S-ium |
0 |
 |
peptide cross-linking via S-glycyl-L-cysteine |
0 |
 |
peptide cross-linking via an oxazole or thiazole + |
0 |
 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
10 |
 |
peptide cross-linking via lanthionine or 3-methyl-lanthionine + |
0 |
 |
| Path 2 |
biological_process |
136531 |
 |
metabolic process |
36512 |
 |
organic substance metabolic process |
32846 |
 |
macromolecule metabolic process |
25254 |
 |
protein metabolic process |
10760 |
 |
protein modification process |
6858 |
 |
cellular protein modification process |
6858 |
 |
peptide cross-linking |
38 |
 |
isopeptide cross-linking + |
1 |
 |
peptide cross-linking via (2S,3S,4Xi,6R)-3-methyl-lanthionine sulfoxide |
0 |
 |
peptide cross-linking via (2S,3S,6R)-3-methyl-lanthionine |
0 |
 |
peptide cross-linking via 2'-(S-L-cysteinyl)-L-histidine |
0 |
 |
peptide cross-linking via 2-(S-L-cysteinyl)-D-allo-threonine |
0 |
 |
peptide cross-linking via 2-(S-L-cysteinyl)-D-phenylalanine |
0 |
 |
peptide cross-linking via 2-(S-L-cysteinyl)-L-phenylalanine |
0 |
 |
peptide cross-linking via 2-imino-glutamic acid 5-imidazolinone glycine |
0 |
 |
peptide cross-linking via 2-imino-glutaminyl-5-imidazolinone glycine |
0 |
 |
peptide cross-linking via 2-imino-methionine 5-imidazolinone glycine |
0 |
 |
peptide cross-linking via 3'-(3'-L-tyrosinyl)-L-tyrosine |
0 |
 |
peptide cross-linking via 3'-(O4'-L-tyrosinyl)-L-tyrosine |
0 |
 |
peptide cross-linking via 3'-(S-L-cysteinyl)-L-tyrosine |
0 |
 |
peptide cross-linking via 3-(2-methylthio)ethyl-6-(4-hydroxybenzylidene)-5-iminopiperazin-2-one |
0 |
 |
peptide cross-linking via 3-(S-L-cysteinyl)-L-aspartic acid |
0 |
 |
peptide cross-linking via 4'-(L-tryptophan)-L-tryptophyl quinone + |
0 |
 |
peptide cross-linking via 4'-(S-L-cysteinyl)-L-tryptophyl quinone |
0 |
 |
peptide cross-linking via 4-(S-L-cysteinyl)-L-glutamic acid |
0 |
 |
peptide cross-linking via 4-amino-3-isothiazolidinone + |
0 |
 |
peptide cross-linking via 5'-(N6-L-lysine)-L-topaquinone |
0 |
 |
peptide cross-linking via 5-imidazolinone glycine + |
0 |
 |
peptide cross-linking via L-cysteinyl-L-selenocysteine |
0 |
 |
peptide cross-linking via L-cystine |
0 |
 |
peptide cross-linking via L-histidyl-L-tyrosine + |
0 |
 |
peptide cross-linking via L-lysinoalanine |
0 |
 |
peptide cross-linking via N6-(L-isoaspartyl)-L-lysine + |
0 |
 |
peptide cross-linking via S-(2-aminovinyl)-3-methyl-D-cysteine |
0 |
 |
peptide cross-linking via S-(2-aminovinyl)-D-cysteine |
0 |
 |
peptide cross-linking via S-(L-isoglutamyl)-L-cysteine |
0 |
 |
peptide cross-linking via S-[5'-(L-tryptoph-6'-yl)-L-tyrosin-3'-yl]-L-methionin-S-ium |
0 |
 |
peptide cross-linking via S-glycyl-L-cysteine |
0 |
 |
peptide cross-linking via an oxazole or thiazole + |
0 |
 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
10 |
 |
peptide cross-linking via lanthionine or 3-methyl-lanthionine + |
0 |
 |
| |
|